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Abstract 
Prostate cancer (PCa) is the most common male neoplasms in the Western world. Various 
risk factors may lead to carcinogenesis, including infectious agents such as polyomavirus BK 
(BKPyV), which infects the human renourinary tract, establishes latency, and encodes 
oncoproteins.  
Previous studies suggested that BKPyV plays a role in PCa pathogenesis. However, the 
unspecific tropism of BKPyV and the lack of in vitro models of BKPyV-infected prostate 
cells cast doubt on this hypothesis.  
The aim of the present study was to determine whether BKPyV could a) infect normal and/or 
tumoral epithelial prostate cells, and b) affect their phenotype. Normal epithelial prostate 
RWPE-1 cells and PCa PC-3 cells were infected with BKPyV for 21 days. Cell proliferation, 
cytokine production, adhesion, invasion ability, and epithelial-to-mesenchymal transition 
(EMT) markers were analyzed. 
Our results show that a) RWPE-1 and PC-3 cells are both infectable with BKPyV, but the 
outcome of the infection varies, b) cell proliferation and TNF-α production were increased in 
BKPyV-infected RWPE-1, but not in PC-3 cells, c) adhesion to matrigel and invasion 
abilities were elevated in BKPyV-infected RWPE-1 cells, d) loss of E-cadherin and 
expression of vimentin occurred in both uninfected and infected RWPE-1 cells. In 
conclusion, BKPyV may change some features of the normal prostate cells, but is not needed 
for maintaining the transformed phenotype in the PCa cells The fact that RWPE-1 cells 
exhibit some phenotype modifications related to EMT represents a limit of this in vitro 
model.  
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Introduction 
Prostate cancer (PCa) is the most common malignant neoplasm in men and the second 
leading cause of cancer-related death in the Western world (NCI-NIH, 2018). Infectious 
agents such as human polyomavirus BK (BKPyV) should be considered as possible risk 
factors for PCa. BKPyV has been classified by the International Agency for Research on 
Cancer as “possibly” carcinogenic to humans due to evidence of carcinogenic activity in vitro 
in cell lines and in vivo in animals (Bouvard et al., 2012). The potential association between 
BKPyV and PCa is supported by previous studies, indicating that BKPyV infection is 
significantly more prevalent in cancer tissues than in control tissues, and that there is a 
significant association between viral expression and cancer (Delbue et al., 2014). However, 
the unspecific tropism of BKPyV and the lack of in vitro models of BKPyV infection in 
prostate cells cast doubt on this hypothesis.  
The “phenotypic switch” from epithelial-to-mesenchymal, also referred to as the epithelial-
to-mesenchymal transition (EMT) process, plays a pivotal role in PCa progression, because it 
makes tumor cells invasive and able to metastasize to distant organs. This EMT phenotype is 
characterized by loss of cell-cell adhesion and epithelial polarity markers (due to 
downregulation of E-cadherin), cytoskeleton reorganization (via expression of vimentin and 
α-smooth muscle actin), abnormal motile properties, and secretion of matrix 
metalloproteinases (MMPs) (Thiery, 2002). 
The main goal of the present study was to determine whether BKPyV could infect normal 
and/or neoplastic prostate epithelial cells and whether this could affect cell morphology, 
proliferation, and adhesive properties, also focusing on EMT markers. For this purpose, we 
used normal human prostate epithelial cell line RWPE-1 and human PCa cell line PC-3. 
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Materials and methods 
Cell cultures 
The RWPE-1 (ATCC® CRL-11609) cell line was established from the epithelial cells of the 
peripheral zone of a normal adult human prostate, transfected with a single copy of human 
papillomavirus 18 (HPV-18). RWPE-1 cells were grown in a keratinocyte serum-free 
medium (K-SFM; GIBCO/Invitrogen, Karlsruhe, Germany) supplemented with 50 µg/mL 
recombinant human epidermal growth factor (rhEGF; GIBCO/Invitrogen, Karlsruhe, 
Germany), 5 ng/mL bovine pituitary extract (BPE; GIBCO/Invitrogen, Karlsruhe, Germany), 
and antibiotics (2.5 µg/mL Fungizone™; GIBCO/Invitrogen, Karlsruhe, Germany;50 U/mL 
penicillin; 50 µg/mL streptomycin; Euroclone, Italy). Human PCa cell line PC-3 (ATCC® 
CRL-1435) was derived from the grade IV prostate adenocarcinoma metastasis of a 62-year-
old Caucasian patient. PC-3 cells were grown and subcultured in nutrient mixture Ham’s F-
12 Coon’s modification medium with L-glutamine (Sigma-Aldrich, Germany) containing 
10% v/v fetal bovine serum and antibiotics (50 U/mL penicillin; 50µg/mL streptomycin; 
Euroclone, Italy). All cells were maintained in an incubator at 37 °C in a 5% CO2 humidified 
atmosphere.  
BKPyV infection 
Cells were infected using 108 virions corresponding to 4 X 106 virus DNA copies/mL 
(calculated by means of Real Time PCR) of BKPyV archetype (WW) strain stock, purchased 
at ATCC® (VR-837). The day before infection, 2 X 106 cells were plated in a T75 flask. On 
day 0, the cells (which reached 70% confluence) were washed twice with Dulbecco’s 
phosphate-buffered saline w/o calcium and magnesium (DPBS; Euroclone, Italy) and then the 
virus stock, diluted with specific serum-free culture medium, was added to the flask. The 
cells were held at 37 °C for 90 min. Then, the inoculum was removed, the cells were washed 
with DPBS in order to eliminate the unbound virus, and the complete medium was added. 
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The uninfected control was created following the same procedure as for the infected cells but 
without the addition of the virus. 
Infected and uninfected cells were continuously cultured with complete medium and were 
split every three days up to 21 days. Aliquots of cells and cell culture supernatants were 
collected for each splitting. Virions were precipitated from the culture medium using PEG-it 
Virus Precipitation Solution (PEG) (System Biosciences, USA) and then treated with DNase 
I; briefly, one part cold PEG (4 °C) was added to every four parts culture medium, 
refrigerated overnight, then processed according to the manufacturer’s protocol. Supernatants 
were diluted 1:1 with nuclease-free water and treated with 5 U DNase I (5 U/µl) (AppliChem, 
Germany) or mock-treated with water. After 1 h at 37 °C, the enzyme was heat- inactivated at 
99 °C for 10 min (Kantola et al., 2009).  
BKPyV DNA isolation and quantitative real-time PCR 
Viral DNA was isolated from the encapsidated virions and from the cell pellet using a 
Nucleospin RNA kit (Macherey-Nagel, Germany) and a QIAamp DNA blood mini kit 
(Qiagen, USA) according to the manufacturer’s instructions. Titration and evaluation of 
extracellular and intracellular viral loads were carried out by BKPyV-specific quantitative 
real-time PCR (Q-PCR). 
BKPyV Q-PCR assays were performed using a TaqMan chemistry with an Applied 
Biosystems 7500 Real-Time PCR System (Applied Biosystems, Carlsbad, CA), targeting the 
highly-conserved VP1 region according to a protocol previously described by Delbue and 
colleagues (Delbue et al., 2010) . A standard curve for quantification of the BKPyV viral load 
was obtained after serial dilution of the plasmid pBKPyV Dunlop with a dilution range 
between 100 and 108 plasmid copies/µL. Negative controls were included in each run and for 
each sample. Standards and controls were tested in triplicate. Data are expressed as viral 
copies/mL. 
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Western Blot  
Western blot analyses targeting BKPyV VP1 (52 kDa), BKPyV LT-Ag proteins (80-94 kDa) 
and α tubulin protein (46-48 kDa) were performed on total protein lysates of BKPyV infected 
and uninfected RWPE-1 and PC-3 cells. As positive control, total protein lysate from BKPyV 
infected VERO cells was used. Cells were collected by scraping and were lysated by an 
incubation of 30 min at 4°C in constant agitation with ice-cold RIPA buffer (Pierce-Thermo 
Scientific, USA) added with 2X protease inhibitor (Halt™ Protease Inhibitor Single-Use 
Cocktail 100x, Pierce-Thermo Scientific, USA). After the incubation, the lysates were 
centrifuged at 4°C for 30 min at full speed. Proteins were separated by electrophoresis on 
10% bis-tris polyacrylamide gels (Biorad) and transferred to a nitrocellulose membrane. 
Then, the nitrocellulose membrane was probed with anti-BKV VP1 (M02) mouse 
monoclonal antibody (cod MAB3204-M02, Abnova) diluted 1:1000, purified mouse 
monoclonal anti-SV40 LT-Ag (PAb416, cod ab16876, Abcam) diluted 1:50 in 5% Non-Fat 
Dry Milk in TBST and anti-α-tubulin (DM1A) mouse monoclonal Ab (cod. 3873; Cell 
Signaling Technology), diluted 1:8000 in 5% Non-Fat Dry Milk in TBST as control. 
We used a horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG antibody (Pierce-
Thermo Scientific) diluted 1:5000 in 5% Non-Fat Dry Milk and the ECL kit (Advansta), to 
visualize proteins on an autoradiography film 
Cell proliferation assay 
The viability of infected and uninfected cells was measured by 3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide (MTT) assay. BKPyV-infected and uninfected cells were 
seeded in 96-well plates (5 X 104 cells per well) and cultured in complete medium at 37 °C 
and 5% CO2 for 24 hours, 48 hours, 72 hours, and 6 days. At each time point, cells were 
washed with DPBS, and after addition of 100 µL MTT (Sigma-Aldrich, Germany), were left 
for 3 hours at 37 °C in the dark. Following incubation, the plate was centrifuged at 1200 rpm 
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for 10 min and then the medium was removed. Dimethyl sulfoxide (DMSO; Sigma-Aldrich, 
Germany) was added to each well to dissolve formazan product crystals, and the plate was 
shaken for 10 min in the dark Absorbance was measured using a BioTek Synergy™ 4 Hybrid 
Microplate Reader (Biotek, USA) at 550 nm. The background, read at 650 nm, was removed. 
Three replicates were made for each group. Cell viability was calculated as follows:  
 
Cell viability %            =           (Absorbance of sample - Absorbance of blank)     × 100 
                                                            Absorbance of negative control 
 
Cytokine, chemokine, and growth factor analysis 
Quantification of 48 different cytokines, chemokines, and growth factors (pro-human 
cytokine 27-Plex M50-0KCAF0Y and 21-Plex MF0-005KMII, Bio-Rad, Hercules, CA) was 
performed on the culture media of both BKPyV-infected and uninfected RWPE-1 and PC-3 
cell lines when cells were split, by magnetic bead-based multiplex immunoassay (Bio-Plex®) 
(BIO-RAD Laboratories, Milano, Italy), according to manufacturer’s instructions. We 
determined the presence and concentration of IL 1α-β-ra-2-2Ra-3-4-5-6-7-8-9-10-12p40 and 
p70-13-15-16-17-18, eotaxin, basic FGF, G-CSF, GM-CSF, IFN-γ, IP10, MCP1-α, MCP1-β, 
PDGFBB, RANTES, TNF-α, VEGF, CTACK, GRO-α, HGF, IFN-α2, LIF, MCP-3, M-CSF, 
MIF, MIG, β-NGF, SCF, SCGF-β, SDF1-α, TNF-β, TRAIL, ICAM1, and VCAM1. We used 
the Bio-Plex 200 reader and a digital processor for data acquisition and output. The Bio-Plex 
Manager® software presented data as median fluorescence intensity (MFI) and concentration 
(pg/mL) (BIO-RAD Laboratories, Milano, Italy), as described previously (Campisciano et al., 
2018). 
Matrigel cell adhesion 
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96-well plates were coated with 200 µL/cm2 Cultrex® Basement Membrane Extract without 
phenol red (BME, PathClear®), a soluble form of basement membrane whose major 
components include laminin, collagen IV, entactin, and heparan sulfate proteoglycan. The 
plates were incubated at 37 °C for 30 min to allow polymerization of the matrix and the wells 
were washed with 1% bovine serum albumin in DPBS to block unspecified cell adhesion. 
Subsequently, infected and uninfected RWPE-1 and PC-3 cells were seeded at 5 X 104 cells 
per well and cultured in their specific complete media at 37 °C and 5% CO2 for 60 min. A 
plastic plate was used as background control. Wells were washed with specific cell-type 
media to remove matrix non-adherent cells. The remaining adherent cells were fixed with 1% 
glutaraldehyde and counted microscopically. The mean cellular adhesion rate (adherent cells 
in coated wells - adherent cells in uncoated wells) was calculated considering three different 
observation fields using a phase-contrast microscope. The invasive characteristics of both cell 
lines were evaluated at days 4, 8, 15, and 21 post-infection, and compared with those of 
uninfected cells. 
Immunofluorescence for EMT marker analysis 
RWPE-1 and PC-3 cells were cultured on 12-mm diameter round coverslips in 24-well 
culture plates. Cells were washed in DPBS, fixed in 4% paraformaldehyde in DPBS 
containing 2% sucrose for 10 min at room temperature, post-fixed in 70% ethanol, and stored 
at -20 °C until use. Then, cells were washed in DPBS three times and incubated for 1 hour at 
room temperature with the primary antibodies anti-E-cadherin (1:2500, Becton Dickinson), 
anti-N-cadherin (1:200, Santa Cruz), anti-vimentin (1:200, Novocastra), and anti-αSMA 
(1:400, Sigma-Aldrich). Secondary antibodies conjugated with Alexa 488 (1:500, Molecular 
Probes, Invitrogen) were applied in DPBS for 1 h at room temperature in the dark. Negative 
controls were incubated in the same way, except for the primary antibody. Cells on coverslips 
were incubated for 15 min with DAPI (1:100.000, Sigma-Aldrich) and mounted onto glass 
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slides using Mowiol. Cells were photographed using a digital camera connected to a Nikon 
Eclipse microscope. 
SDS-zymography for invasive potential analysis 
Culture media were mixed 3:1 with sample buffer containing 10% SDS. Samples (10 μg total 
protein per sample) were run under non-reducing conditions without heat denaturation on 10% 
polyacrylamide gel (SDS-PAGE) co-polymerized with 1 mg/mL type I gelatin at 4 °C. After 
SDS-PAGE, gels were washed twice in 2.5% Triton X-100 for 30 min each and incubated 
overnight in a substrate buffer at 37 °C (Tris-HCl 50 mM, CaCl2 5 mM, NaN3 0.02%, pH 
7.5). After staining the gels with Coomassie Brilliant Blue R-250, MMP gelatinolytic activity 
was detected as clear bands on a blue background, quantified by densitometric scanning 
(UVBand, Eppendorf, Italy). 
Tissue inhibitor of metalloproteinase-2 real-time PCR 
Tissue inhibitor of metalloproteinase-2 (TIMP-2) gene expression was analysed by real-time 
PCR. Total RNA was isolated by a modified version of the acid guanidinium thiocyanate-
phenol-chloroform method (Tri-Reagent, Sigma, Italy). 1 µg total RNA was reverse-
transcribed in 20 µL (final volume) reaction mix (Biorad, Segrate-Milan, Italy). TIMP-2 
mRNA levels were assessed and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was 
used as an endogenous control to normalize differences in the amount of total RNA in each 
sample. The primer sequence was sense CCCTTCATTGACCTCAACTACATG, antisense 
TGGGATTTCCATTGATGACAAGC for GAPDH and sense 
TGGAAACGACATTTATGGCAACCC, antisense CTCCAACGTCCAGCGAGACC for 
TIMP-2. 
Amplification reactions were conducted in a 96-well plate in a final volume of 20 µL per 
well. Each well contained 10 µL 1X SYBR Green Supermix (BioRad, Italy), 2 µL template, 
and 300 pmol of each primer. Each sample was analysed in triplicate in a Bioer LineGene 
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9600. The cycle threshold was determined and gene expression levels relative to that of 
GAPDH were calculated. 
Electronic microscopy for morphological analysis 
RWPE-1 cells, grown at confluence, were harvested at 250 g for 5 min at room temperature. 
The culture medium was removed and replaced with a solution containing 2% freshly 
prepared paraformaldehyde and 2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 
7.4). Cells were fixed for 2–4 h at 4 °C, then were centrifuged and rinsed twice in cacodylate 
buffer for 20 min, post-fixed in 1% osmium tetroxide in the same buffer at 0 °C for 30 min, 
washed in distilled water, and en bloc stained with 2% aqueous uranyl acetate. After 
dehydration in a graded acetone series, samples were embedded in Epon-Araldite resin. 
Ultrathin sections (70–100 nm) were cut on a Leica Supernova ultramicrotome and stained 
with Reynolds’ lead citrate. Transmission electron microscopy was performed with a Zeiss 
EM10 electron microscope. 
Statistical analysis 
All experiments were performed three to six times. Statistical significance was assessed using 
the Wilcoxon-Mann-Whitney U test. Differences were considered statistically significant at p 
< 0.05. Linear regression was performed for analysing changes in cytokine concentration 
over time. 
Results 
BKPyV infection – Viral DNA analysis 
RWPE-1 and PC-3 cell lines were infected in vitro with a BKPyV archetype strain. Viral 
extracellular and intracellular DNA was quantified by specific Q-PCR at different time points 
postinfection. Both normal and cancerous epithelial prostate cell lines were found to be 
infectable with BKPyV, although a different time course of infection was observed in each 
cell line. Infection peaked on day 3 p.i. in RWPE-1 cells, with an extracellular viral load of 
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4.0 X 106 copies/mL and an intracellular viral load of 2.3 X 106 copies/mL. Viral replication 
was observed until day 14 p.i. (culture medium: undetectable; cell pellet: 7.7 X 102 
copies/mL) (Figure 1A). In the PC-3 cell line, infection peaked on day 10 p.i., and the virus 
remained productive over 21 days p.i. with a mean extracellular viral load of 6.9 X 105 
copies/mL (range: 8.7 X 103–2.6 X 106 copies/mL) and an intracellular viral load of 1.7 X 
106 copies/mL (range: 2.4 X 105–3.9 X 106 copies/mL) (Figure 1B). Uninfected RWPE-1 and 
PC-3 did not harbour BKPyV genome or other DNA naked virus genomes (JC polyomavirus, 
SV40 polyomavirus, parvovirus, adenovirus), except for HPV-18, used for the 
immortalization of the RWPE-1 (data not shown). 
BKPyV infection – protein expressions 
Expression of BKPyV LT-Ag and VP1 proteins, as markers for early and late gene 
expression, respectively was examined in RWPE- 1 and PC-3 cells at 3,6 and 10 days p.i.. 
LT-Ag expression was detected at 10 days p.i. in RWPE-1 (Figure 2, panel A) and at all the 
analysed times p.i. in PC-3 cells (Fig. 2 panel B). VP1 expression was detected at 6 and 10 
days p.i. in RWPE-1 (Figure 2, panel A), but was not detected in PC-3 at any analysed times 
p.i. (Figure 2, panel B)  
BKPyV infection affects RWPE-1 cell proliferation 
An MTT assay was performed on infected and uninfected cells to evaluate the effect of 
BKPyV infection on the growth rate of RWPE-1 and PC-3 cells. Infected cell viability was 
normalized to the viability of uninfected cells. Infected RWPE-1 cells showed a higher rate of 
proliferation compared to uninfected cells (range +25%/+58%, p < 0.05) (Figure 3A), 
whereas infected PC-3 cells displayed a significantly lower rate of proliferation than 
uninfected cells (range: -37%/-73%, p < 0.05) (Figure 3B). 
BKPyV infection induces significant expression of inflammatory factors and activators in 
RWPE-1 cells 
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A panel of 48 cytokines and chemokines was analysed at seven time points p.i (24 and 48 
hours; 3, 7, 12, 17, and 21 days) in the culture supernatants of infected and uninfected 
RWPE-1 and PC-3 cells (Table 1). The concentration of three factors involved in the tumor 
inflammatory microenvironment (IL-18, TNF-α, and MCP1) increased significantly in the 
supernatant of RWPE-1 infected cells compared to mock-infected counterparts (linear trend 
estimation: R2 ≥ 0.6, p ≤ 0.04; Figure 4A, B, and C). In particular, the concentration of the 
proinflammatory cytokine TNF-α in the supernatant of the RWPE-1 infected cells showed a 
linear increase from 1.13 pg/mL at hour 24 to 6.86 pg/mL on day 21 (R2 = 0.9, p < 0.0001). 
This increase was much greater than in uninfected cells (on average 1.58 ± 0.18 pg/ml from 
24 hours to 21 days). On the other end, the concentration of IL-3, a strong inducer of the 
active immune response, decreased significantly in the supernatant of infected RWPE-1 cells 
from 34.10 pg/ml at hour 24 to 6.58 pg/ml on day 21, compared to uninfected counterparts 
(4.77 to 48.05 pg/ml). The linear trend for IL-3 showed the significant effect of BKPyV 
infection on constitutive cytokine expression (R2 = 0.56, p < 0.05) (Figure 4D). No significant 
linear trends were observed in the levels of cytokine/chemokine production between infected 
and uninfected PC-3 cells (table 1).   
Matrigel adhesion assay  
Both cell lines were seeded on BME, which mimics the extracellular matrix, to investigate 
the effect of BKPyV infection on the invasive behaviour of RWPE-1 and PC-3 cells. The 
binding rate of infected cells per mm2 was calculated. Results were normalized to the binding 
rate of uninfected cells. Both infected cell lines showed a higher binding rate compared to 
their mock treated counterparts. The rate was from +17% to +1570% for RWPE-1 cells and 
from +9% to +811% for PC-3 cells (Figure 5, panels A and B).  
EMT marker analysis  
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EMT marker expression was assessed by immunofluorescence in both infected and 
uninfected RWPE-1 cells. At all time points, uninfected RWPE-1 cells exhibited low or 
undetectable levels of E-cadherin. Immunoreactivity was observed mostly in the cytoplasm 
and not in cell boundaries, in which functional adherent junctions are located in normal 
differentiated epithelial cells. Infected RWPE-1 cells showed a similar pattern of E-cadherin 
expression. N-cadherin expression was almost undetectable, with scattered positive cells in 
both infected and uninfected RWPE-1 cells. Vimentin expression was similar in infected and 
uninfected RWPE-1 cells (Figure 6, panel A). 
To better investigate the effect of BKPyV on normal epithelial cells and its possible 
involvement in PCa oncogenesis, the expression of EMT markers was analysed in PC-3 cells 
before and after BKPyV infection. As expected, E-cadherin was almost completely 
undetectable in both infected and uninfected PC-3 cells at all time points. N-cadherin and 
vimentin expression were similarly expressed in control and BKPyV-infected PC-3 cells 
(Figure 6, panel B). 
Invasive potential 
To determine the invasive potential of infected and uninfected RWPE-1 and PC-3 cells, 
MMP-2 and MMP-9 gelatinolytic activity in cell supernatants was assessed by SDS-
zymography. Densitometric scanning of lytic bands on zymograms revealed that MMP-2 and 
MMP-9 were similarly expressed in uninfected and infected RWPE-1 cells up to day 3. At all 
subsequent time points, MMP-2 and MMP-9 were strongly induced in BKPyV-infected cells 
compared to uninfected cells (Figure 7, panel A and B). 
Densitometric analysis of lytic bands also showed that the activity of MMP-2 and MMP-9 in 
PC-3 cells were differently affected by BKPyV infection in a time-dependent manner that 
could not be properly defined (data not shown). To assess whether the invasive potential of 
PC-3 cells was influenced by BKPyV infection, we analysed the expression of TIMP-2, a 
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natural inhibitor of MMP-2, and described MMP-2 and MMP-9 activity in relation to TIMP-2 
expression. The MMP-2:TIMP-2 ratio was strongly increased by BKPyV from day 3 to day 
14, and thereafter, was similar to that in control cells. A comparable pattern was observed in 
the MMP-9:TIMP-2 ratio (Figure 7, panel C). 
Morphological analysis by electron microscopy 
The morphology and ultrastructure of infected and uninfected RWPE-1 cells at different time 
points were analysed by electron microscopy. For each pellet, 120 cells were photographed 
and evaluated to observe the presence of any viral particles. Both uninfected and infected 
cells showed similar morphologies (Figure 8, panel A) and contained a high number of viral 
particles (Figure 8, panel B). Unexpectedly, viral particles were observed in both infected and 
uninfected RWPE-1 cells, although BKPyV DNA and proteins were undetectable by Q-PCR 
and western blot, respectively. 
Discussion 
BKPyV is a member of the Polyomaviridae family with very well-known in vitro oncogenic 
properties, mainly resulting from the production of the large T antigen protein, which is able 
to induce cell transformation (Tognon et al., 2003). Based on serological and molecular 
studies, it has been suggested that BKPyV may be involved in the etiology and/or 
development of PCa (Delbue et al., 2014; Keller et al., 2015). However, it remains uncertain 
whether BKPyV infection is a causative agent in PCa or an epiphenomenon. The lack of an in 
vitro model of BKPyV-infected epithelial prostate cells represents a major limitation.  
In the present study, we infected prostate cells with BKPyV with the aim of establishing and 
characterizing an in vitro model to obtain further insight into the relationship between viral 
activity and possible phenotypic changes. 
We demonstrated for the first time that both normal epithelial prostate cell line RWPE-1 and 
PCa cell line PC-3 are infectable with BKPyV. Moreover, we showed that the outcomes of 
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the infection varies in the two cell lines, being the viral DNA lost from RWPE-1 by day 14 
p.i., but persisting in PC-3 up to three weeks p.i. BKPyV was capable of expressing early and 
late proteins LT-Ag and VP1 within RWPE-1, but only LT-Ag in PC-3. These findings 
suggest that normal prostate cells are subjected to a transient infection. On the other hand, 
PC-3 cells seem to maintain a steady state of BKPyV replication over time, limiting protein 
expression to early LT-Ag. Therefore, it is plausible that a persistent infection was 
established in PC-3 cells. 
Our results are difficult to compare with those from other studies, as previous experiments on 
BKPyV infection in vitro have been performed in human or monkey kidney cells, lung 
fibroblasts, or epithelial cells from salivary glands (Acott et al., 2006; Jeffers-Francis et al., 
2015; Li et al., 2013). Despite the quick lost of the infection, BKPyV seems to affect some of 
the properties of normal prostate cells, such as their proliferation rate and the production of 
factors possibly involved in malignant transformation. 
TNF-α is a pleiotropic cytokine that can induce cancer cell death, but may also favor cell 
proliferation under certain specific conditions (Tse et al., 2012). In addition, TNF-α 
orchestrates the expression of inflammatory cytokines involved in the development of 
castrate-resistant PCa, such as IL-6 (Nguyen et al., 2014). Interestingly, TNF-α showed a 
strong growth-stimulating effect on simian polyomavirus 40-transformed keratinocytes 
(Kobayashi et al., 1999), and a similar effect on BKPyV-infected prostate cells can be 
hypothesized, upon synergic stimulation of proliferation with viral LT-Ag.  
The concomitant upregulation of TNF-α, IL-18, and MPC-1 upon BKPyV infection might 
contribute to the promotion of prostatic cells toward a cancerous phenotype (Ito et al., 2015; 
Palma et al., 2013). In addition, the role of IL-18 as a potent inducer of IFN-γ, suggests a 
relevant role of BKPyV in PCa development and progression (Feder-Mengus et al., 2008). 
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Finally, the inhibition of IL-3 production should help BKPyV evade the host innate immune 
response (Broughton et al., 2012). 
On the contrary, infected PC-3 cells showed a decrease in their proliferation rate, probably 
due to the cytopathic effect and stable expression of TNF-α after BKPyV infection.  
We evaluated the binding of BKPyV-infected RWPE-1 and PC-3 cells to the extracellular 
matrix because direct interaction with the extracellular matrix may lead to transendothelial 
invasion. BKPyV-infected cells showed higher adhesion to Matrigel than uninfected cells, 
even though there was no specific trend over time. Further comparison demonstrated that 
infected PC3 cells had more adhesion capability than infected RWPE-1. The inverse 
relationship between E-cadherin expression and adhesion to Matrigel was previously 
described by Jannesari-Ladani et al. who suggested a more destabilized E-cadherin-based 
adhesion in PC-3 cells (Jannesari-Ladani et al., 2014).  
Higher levels and activity of MMP-2 and MMP-9 in BKPyV-infected RWPE-1 showed that 
the virus elicited an invasive phenotype in normal cells. Increased expression of MMP-2 and, 
consequently, strong invasive behavior of the cells has previously been described in a 
transgenic mouse model with polyomavirus-induced osteosarcoma (Velupillai et al., 2010). 
Very recently, the induction of several MMPs has been described in an in vitro model of 
Merkel cell carcinoma induced by Merkel cell polyomavirus; the authors hypothesized that 
dysregulated MMP gene expression may contribute to virus-induced oncogenesis (Liu et al., 
2016). Both enhanced cell adhesion to the extracellular matrix and increased activity of 
MMP-2 and MMP-9 have been observed even after clearance of the BKPyV genome from 
the RWPE-1 cells.  
The increased levels and activity of MMPs induced by BKPyV in PC-3 cells suggests that the 
viral DNA replication was effective in adding invasive potential to already established 
invasive properties.  
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Although all the above evidence could reasonably lead to the hypothesis that BKPyV 
catalyses some changes in RWPE-1 cells, we observed an unexpected result regarding EMT 
markers and the EMT-related phenotype. Uninfected RWPE-1 cells are normal epithelial 
cells, but our data shows that they do not present a clear epithelial phenotype; E-cadherin 
downregulation and cytoplasmic localization was detected in most cells, and vimentin 
expression was observed in both control and BKPyV-infected cells, thus suggesting that 
uninfected cells underwent EMT. This finding was consistent with the morphological results 
in the same cells as described by Tam and colleagues. (Tam et al., 2017). To better 
understand this unexpected result, we analyzed RWPE-1 cells by electron microscope. Small 
viral particles were detected not only in BKPyV-infected cells, but also in normal, uninfected 
RWPE-1 prostate cells, although BKPyV viral DNA and proteins were undetectable, 
suggesting that these viral particles were a result of HPV-18 used for RWPE-1 
immortalization.  
It is likely that RWPE-1 cells, which have been immortalized with a defective HPV-18 
genome, are still able to produce viral capsid proteins (known as L1), which spontaneously 
self-assemble into a structure closely mimicking the natural surface of native papillomavirus 
virions (Buck et al., 2013). The concomitant presence of these pseudovirions and the 
observation of an EMT-related phenotype in uninfected RWPE-1 cells strongly suggests that 
RWPE-1 cells do not retain a normal epithelial morphology (Bello et al., 1997) and may not 
serve as a model of normal epithelial prostate cells, even if they are used for  research 
purpose (Deng et al., 2017; Souza et al., 2018). BKPyV-infected and uninfected RWPE-1 
cells exhibit a similar EMT phenotype, suggesting that uninfected cells do not retain normal 
epithelial characteristics and thus their use as a model of normal epithelial prostate cells may 
be limited. However, under our experimental conditions, we were able to demonstrate that 
BKPyV infection induced increased gelatinolytic activity in RWPE-1 cells, allowing us to 
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detect the effect of BKPyV in inducing the invasive properties of infected cells, consistent 
with their malignant transformation. Previous reports have described aberrant expression of 
E-cadherin and vimentin in normal prostate tissues (Figiel et al., 2017; Rubin et al., 2001), 
indicating that further research is necessary to understand whether the EMT morphological 
features of untreated RWPE-1 cells are induced by HPV and validate the use of these cells as 
an experimental model for normal prostate epithelial cells. 
As expected, PC-3 carcinoma cells were characterized by an EMT phenotype and no 
additional morphological modifications were induced by BKPyV infection. In contrast, 
BKPyV infection increased their invasive potential. 
Considered as a whole, our results show that a) normal epithelial prostate RWPE-1 cells and 
PC-3 cells are infectable with BKPyV, but the outcomes of infection vary, b) cell 
proliferation and TNF-α production were increased by BKPyV in RWPE-1 cells, but not in 
PC-3 cells, c) adhesion to Matrigel and invasion potential, observed as MMP-2 and MMP-9 
activities, were increased upon BKPyV infection of RWPE-1 cells, d) both mock treated and 
BKPyV-infected RWPE-1 cells exhibit loss of E-cadherin and expression of vimentin. 
In conclusion, we hypothesize that BKPyV may establish a transient infection in normal 
epithelial prostate cells and change some phenotypic features, such as the proliferation, 
adhesion and invasive potential, but then it is not needed for maintaining the transformed 
phenotype of prostate tumor cells. However, the fact that mock treated RWPE-1 cells exhibit 
some phenotype modifications related to EMT represents a limit of this in vitro model.  
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Table 1: Cytokine and chemokine concentration trends in BKPyV-infected RWPE-1 and PC-
3 cells 
 
Cytokine/chemokine 
Linear trend estimation*,** 
RWPE-1 PC-3 
IL-18 R2 0.69; p=0.02 R2 0.89; p=0.09 
TNF-α R2 0.85; p<0.01 R2 0.61; p=0.80 
MCP1 R2 0.59; p=0.04 R2 0.86; p=0.17 
IL-15 R2 0.24; p=0.26 n.a. 
IL-2 R2 0.4; p=0.12 R2 0.13; p=0.26 
IL-6 R2 0.03; p=0.71 R2 0.80; p=0.42 
IL-9 R2 0.07; p=0.55 R2 0.20; p=0.07 
GM-CSF R2 0.3; p=0.1 R2 0.39; p=0.4 
FGF-basic R2 0.21; p=0.29 R2 0.99; p=0.12 
MIP-1a R2 0.26; p=0.24 R2 0.59; p=0.06 
MIP-1b R2 0.04; p=0.95 R2 0.01; p=0.60 
IL-3 R2 0.56; p=0.05 R2 0.96; p=0.36 
M-CSF R2 0.03; p=0.70 R2 0.74; p=0.66 
SDF-1 R2 0.29; p=0.20 R2 0.89; p=0.64 
*compared to uninfected RWPE-1 cells 
**from 1 to 21 days p.i. 
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Figure captions 
Figure 1: Titration of BKPyV load, expressed as copies/mL, in RWPE-1 (Panel A) and PC-3 
(Panel B) culture media and cell pellets, at every analyzed time points, from day 1 to day 21 
p.i.. 
 
Figure 2: Expression of BKV early and late proteins in RWPE-1 (Panel A) and PC-3 (Panel 
B) cells. Total cellular protein isolated at the indicated times p.i. (3,6 and 10 days) was 
analyzed as described in Metarials and methods section. As negative control (C-), total 
protein isolated from uninfected RWPE- 1 or PC-3 cells was used; as positive control (C+), 
total protein isolated from BKPyV infected VERO cells was used.  
 
Figure 3: Effect of BKPyV infection on the growth rate of RWPE-1 (Panel A) and PC-3 
(Panel B) cells measured by the MTT assay. Data are expressed as percentage of the cell 
viability, compared to the uninfected cells (100%). 
 
Figure 4: Concentration of four most significant cytokines (Panel A: IL-18; panel B: TNF-α; 
panel C: MCP1; and  panel D: IL-3), measured in the culture medium of the infected and 
uninfected RWPE-1 cells, at every analyzed time points, from day 1 to day 21 p.i. Data are 
expressed as pg/mL and as percentage of increase. Linear trend estimation is indicated for 
every cytokines. 
 
Figure 5: Panel A and B represent the percentage of adhesion rate to the extracellular matrix 
of the BKPyV infected RWPE-1 and PC-3, respectively, at different time points, from 4 to 21 
days p.i.. Adhesion capacity is depicted as percentage of cell adhesion/square millimeter 
(mean± SD), compared to uninfected cells (100%).  
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Figure 6: Panel A) Representative micrographs at the fluorescence microscope showing the 
expression of epithelial and mesenchymal markers in control and BKPyV-infected RWPE-1 
cells 7 days p.i. (original magnification 60x). Panel B) Representative micrographs at the 
fluorescence microscope showing the expression epithelial and mesenchymal markers in 
control and BKPyV-infected PC-3 cells 21 days p.i.  (original magnification 60x). 
 
Figure 7: Panel A) Representative gelatin zymogram and bar graphs showing MMP-2 (panel 
B) and MMP-9 (panel C) activity in supernatants of cultured control and BKPyV-infected 
RWPE-1 cells. Data are expressed as mean ± SD. Representative gelatin zymogram and bar 
graphs showing MMP-/TIMP-2 (panel D) ratio and MMP-9/TIMP-2 ratio (panel E) activity 
in supernatants of cultured control and BKPyV-infected PC3 cells. Data are expressed as 
mean ± SD. 
 
Figure 8: Panel A) Transmission electron micrographs of RWPE-1 non infected (a) and 
BKPyV-infected-RWPE-1 (b) cells at 3 days showing a similar morphology. Scale bars = 0,5 
µm. Boxed areas show at higher magnification the viral particles present in both experimental 
conditions. Scale bars = 200 nm. Panel B) Transmission electron micrographs of RWPE-1 
non infected (c) and BKPyV-infected-RWPE-1 (d) cells at 10 days p.i. containing viral 
particles (some indicated by white arrows). Scale bars = 0,5 µm. A viral particle from each 
experimental condition is shown at higher magnification in boxed areas. Scale bars = 120 nm. 
 
 








